Halliburton insider plans $566K stock sale

HALLIBURTON CO (HAL) received a notice under Rule 144 that Jeffrey Shannon Slocum, through Fidelity Brokerage Services LLC as attorney-in-fact, intends to sell 16,121 shares of Halliburton common stock on or after August 18, 2026 on the NYSE.

Rhea-AI Filing Summary

HALLIBURTON CO (HAL) received a notice under Rule 144 that Jeffrey Shannon Slocum, through Fidelity Brokerage Services LLC as attorney-in-fact, intends to sell 16,121 shares of Halliburton common stock on or after August 18, 2026 on the NYSE. These shares relate to restricted stock vesting dated April 27, 2025, with an indicated aggregate market value of $565,577.90.

Key Figures

Shares planned for sale: 16,121 shares Aggregate market value: $565,577.90 Planned sale date: 08/18/2026 +2 more

5 metrics

Shares planned for sale 16,121 shares Common stock to be sold under Rule 144

Aggregate market value $565,577.90 Value associated with the 16,121 shares to be sold

Planned sale date 08/18/2026 Date listed for NYSE sale of the shares

Restricted stock vesting date 04/27/2025 Date the compensation-related restricted stock vested

Issuer phone number 2818712699 Contact phone for Halliburton’s listed address

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 04/27/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for J.Shannon Slocum"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"16121 | 04/27/2025 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for HAL disclose about upcoming stock sales?

The filing discloses a planned sale of 16,121 shares of Halliburton common stock under Rule 144. The sale is planned through Fidelity Brokerage Services LLC on or after August 18, 2026, based on previously vested restricted stock.

Who is the selling security holder in Halliburton (HAL)'s Form 144?

The selling security holder is Jeffrey Shannon Slocum. Fidelity Brokerage Services LLC signed the notice as attorney-in-fact and duly authorized representative for Slocum in connection with the planned Rule 144 sale.

How many Halliburton (HAL) shares are covered by this Form 144?

The notice covers 16,121 shares of Halliburton common stock. These shares are associated with restricted stock vesting on April 27, 2025, and are intended to be sold in compliance with Rule 144 requirements.

What is the aggregate market value of the Halliburton (HAL) shares in this Form 144?

The filing lists an aggregate market value of $565,577.90 for the 16,121 shares of Halliburton common stock. This figure reflects the value used in the notice for the planned Rule 144 sale through Fidelity.

On which exchange are the Halliburton (HAL) shares in this Form 144 expected to be sold?

The shares are expected to be sold on the NYSE. The Form 144 identifies Halliburton common stock to be sold under Rule 144, with the exchange specified as the New York Stock Exchange in the securities information section.

What is the origin of the Halliburton (HAL) shares being sold under this Form 144?

The shares arise from restricted stock vesting on April 27, 2025. The Form 144 notes the acquisition was from the issuer as compensation, and these vested shares are now subject to a planned Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 04:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001970357
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HALLIBURTON CO
SEC File Number	001-03492
Address of Issuer	3000 NORTH SAM HOUSTON PARKWAY EAST 3000 NORTH SAM HOUSTON PARKWAY EAST HOUSTON TEXAS 77032
Phone	2818712699
Name of Person for Whose Account the Securities are To Be Sold	Slocum Jeffrey Shannon
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	16121	565577.90	833130367	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2025	Restricted Stock Vesting	Issuer			16121	04/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for J.Shannon Slocum
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)